Natco Pharma proposes to acquire Dash Pharmaceuticals
According to a press release issued by the Hyderabad-based drug maker, Dash is a front-end pharmaceutical sales, marketing and distribution entity based in New Jersey, USA which is expected to have approximate net sales of USD 15 million for the year ending December 2021.